33 related articles for article (PubMed ID: 17927880)
1. Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer.
Ji K; Sameni M; Osuala K; Moin K; Mattingly RR; Sloane BF
Cancer Metastasis Rev; 2019 Sep; 38(3):445-454. PubMed ID: 31605250
[TBL] [Abstract][Full Text] [Related]
2. The Research Progress in Physiological and Pathological Functions of TRAF4.
Ruan X; Zhang R; Li R; Zhu H; Wang Z; Wang C; Cheng Z; Peng H
Front Oncol; 2022; 12():842072. PubMed ID: 35242717
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic TRAF4 contributes to the activation of p70s6k signaling pathway in breast cancer.
Ren HY; Wang J; Yang F; Zhang XL; Wang AL; Sun LL; Diao KX; Wang EH; Mi XY
Oncotarget; 2015 Feb; 6(6):4080-96. PubMed ID: 25738361
[TBL] [Abstract][Full Text] [Related]
4. TRAF4 participates in Wnt/β-catenin signaling in breast cancer by upregulating β-catenin and mediating its translocation to the nucleus.
Wang A; Wang J; Ren H; Yang F; Sun L; Diao K; Zhao Z; Song M; Cui Z; Wang E; Wei M; Mi X
Mol Cell Biochem; 2014 Oct; 395(1-2):211-9. PubMed ID: 24990246
[TBL] [Abstract][Full Text] [Related]
5. Expression and anti-apoptotic function of TRAF4 in human breast cancer MCF-7 cells.
Zhang X; Wen Z; Mi X
Oncol Lett; 2014 Feb; 7(2):411-414. PubMed ID: 24396457
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells.
Wang X; Jin C; Tang Y; Tang LY; Zhang YE
J Biol Chem; 2013 Jul; 288(30):21784-92. PubMed ID: 23760265
[TBL] [Abstract][Full Text] [Related]
7. [Remodeling of basement membrane in association with cancer invasion].
Nakano S; Tsuruta J; Iyama K
Rinsho Byori; 2000 May; 48(5):451-7. PubMed ID: 10892294
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and morphologic features and methods of treatment of non-invasive breast cancer].
Semiglazov VV; Semiglazov VF
Vopr Onkol; 2001; 47(3):278-89. PubMed ID: 11544824
[No Abstract] [Full Text] [Related]
9. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
11. [Loss of fragile histidine triad expression and metastasis in breast cancer].
Zhao P; Li XY; Chen LZ
Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
[TBL] [Abstract][Full Text] [Related]
12. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
13. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of TRAF4 protein in breast carcinoma].
Dai WB; Zheng YW; Mi XY; Liu N; Lin H; Yan J
Ai Zheng; 2007 Oct; 26(10):1095-8. PubMed ID: 17927880
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
